Global TB Diagnostics Market Size, Share, and COVID-19 Impact Analysis By Test Type (Radiographic Test, Laboratory Test, Nucleic Acid Testing, Cytokine Detection Test, Drug Resistance Test, and Other Diagnostic Test Types), By End-User (Hospital/Clinics, Diagnostics/Research Laboratory, and Other End Users), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2021 - 2030.
Industry: Healthcare- Introduction
- Objectives of the Study
- Market Definition
- Research Scope
- Research Methodology and Assumptions
- Executive Summary
- Premium Insights
- Porter’s Five Forces Analysis
- Value Chain Analysis
- Top Investment Pockets
- Market Attractiveness Analysis By Test Type
- Market Attractiveness Analysis By End-User
- Market Attractiveness Analysis By Region
- Industry Trends
- Market Dynamics
- Market Evaluation
- Drivers
- Increase in the prevalence of tuberculosis
- Restraints
- High cost of tuberculosis diagnostics
- Opportunities
- The increasing number of market approval
- Challenge
5.5.1. Limitations of existing tuberculosis
- Global TB Diagnostics Market Analysis and Projection, By Test Type
- Segment Overview
- Radiographic Test
- Laboratory Test
- Nucleic Acid Testing
- Cytokine Detection Test
- Drug Resistance Test
- Other Diagnostic Test Types
- Global TB Diagnostics Market Analysis and Projection, By End-User
- Segment Overview
- Hospital/Clinics
- Diagnostics/Research Laboratory
- Other
- Global TB Diagnostics Market Analysis and Projection, By Regional Analysis
- Segment Overview
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Asia-Pacific
- Japan
- China
- India
- South America
- Brazil
- Middle East and Africa
- UAE
- South Africa
- Global TB Diagnostics Market -Competitive Landscape
- Overview
- Market Share of Key Players in the TB Diagnostics Market
- Global Company Market Share
- North America Company Market Share
- Europe Company Market Share
- APAC Company Market Share
- Competitive Situations and Trends
- Coverage Launches and Developments
- Partnerships, Collaborations, and Agreements
- Mergers & Acquisitions
- Expansions
- Company Profiles
- Thermo Fisher Scientific Inc.
- Business Overview
- Company Snapshot
- Company Market Share Analysis
- Company Coverage Portfolio
- Recent Developments
- SWOT Analysis
- Becton Dickinson and Company
- Business Overview
- Company Snapshot
- Company Market Share Analysis
- Company Coverage Portfolio
- Recent Developments
- SWOT Analysis
- Hoffmann-La Roche Ltd.
- Business Overview
- Company Snapshot
- Company Market Share Analysis
- Company Coverage Portfolio
- Recent Developments
- SWOT Analysis
- Qiagen NV
- Business Overview
- Company Snapshot
- Company Market Share Analysis
- Company Coverage Portfolio
- Recent Developments
- SWOT Analysis
- BioMerieux SA
- Business Overview
- Company Snapshot
- Company Market Share Analysis
- Company Coverage Portfolio
- Recent Developments
- SWOT Analysis
- Oxford Immunotec Ltd.
- Business Overview
- Company Snapshot
- Company Market Share Analysis
- Company Coverage Portfolio
- Recent Developments
- SWOT Analysis
- Cepheid Inc.
- Business Overview
- Company Snapshot
- Company Market Share Analysis
- Company Coverage Portfolio
- Recent Developments
- SWOT Analysis
- Akonni Biosystems Inc.
- Business Overview
- Company Snapshot
- Company Market Share Analysis
- Company Coverage Portfolio
- Recent Developments
- SWOT Analysis
- PAR Pharmaceuticals
- Business Overview
- Company Snapshot
- Company Market Share Analysis
- Company Coverage Portfolio
- Recent Developments
- SWOT Analysis
- Alere Inc. (Abbott)
- Business Overview
- Company Snapshot
- Company Market Share Analysis
- Company Coverage Portfolio
- Recent Developments
- SWOT Analysis
- Lionex GmbH
- Business Overview
- Company Snapshot
- Company Market Share Analysis
- Company Coverage Portfolio
- Recent Developments
- SWOT Analysis
- Creative Diagnostics
- Business Overview
- Company Snapshot
- Company Market Share Analysis
- Company Coverage Portfolio
- Recent Developments
- SWOT Analysis
- Thermo Fisher Scientific Inc.
List of Table
- Global TB Diagnostics Market, By Test Type, 2022-2030(USD Billion)
- Global Radiographic Test, TB Diagnostics Market, By Region, 2022-2030(USD Billion)
- Global Laboratory Test, TB Diagnostics Market, By Region, 2022-2030(USD Billion)
- Global Nucleic Acid Testing, TB Diagnostics Market, By Region, 2022-2030(USD Billion)
- Global Cytokine Detection Test, TB Diagnostics Market, By Region, 2022-2030(USD Billion)
- Global Drug Resistance Test, TB Diagnostics Market, By Region, 2022-2030(USD Billion)
- Global Other Diagnostic Test Types, TB Diagnostics Market, By Region, 2022-2030(USD Billion)
- Global TB Diagnostics Market, By End-User, 2022-2030(USD Billion)
- Global Hospital/Clinics, TB Diagnostics Market, By Region, 2022-2030(USD Billion)
- Global Diagnostics/Research Laboratory, TB Diagnostics Market, By Region, 2022-2030(USD Billion)
- Global Other End Users, TB Diagnostics Market, By Region, 2022-2030(USD Billion)
- Global TB Diagnostics Market, By Region, 2022-2030(USD Billion)
- North America TB Diagnostics Market, By Test Type, 2022-2030(USD Billion)
- North America TB Diagnostics Market, By End-User, 2022-2030(USD Billion)
- U.S. TB Diagnostics Market, By Test Type, 2022-2030(USD Billion)
- U.S. TB Diagnostics Market, By End-User, 2022-2030(USD Billion)
- Canada TB Diagnostics Market, By Test Type, 2022-2030(USD Billion)
- Canada TB Diagnostics Market, By End-User, 2022-2030(USD Billion)
- Mexico TB Diagnostics Market, By Test Type, 2022-2030(USD Billion)
- Mexico TB Diagnostics Market, By End-User, 2022-2030(USD Billion)
- Europe TB Diagnostics Market, By Test Type, 2022-2030(USD Billion)
- Europe TB Diagnostics Market, By End-User, 2022-2030(USD Billion)
- Germany TB Diagnostics Market, By Test Type, 2022-2030(USD Billion)
- Germany TB Diagnostics Market, By End-User, 2022-2030(USD Billion)
- France TB Diagnostics Market, By Test Type, 2022-2030(USD Billion)
- France TB Diagnostics Market, By End-User, 2022-2030(USD Billion)
- U.K. TB Diagnostics Market, By Test Type, 2022-2030(USD Billion)
- U.K. TB Diagnostics Market, By End-User, 2022-2030(USD Billion)
- Italy TB Diagnostics Market, By Test Type, 2022-2030(USD Billion)
- Italy TB Diagnostics Market, By End-User, 2022-2030(USD Billion)
- Spain TB Diagnostics Market, By Test Type, 2022-2030(USD Billion)
- Spain TB Diagnostics Market, By End-User, 2022-2030(USD Billion)
- Asia Pacific TB Diagnostics Market, By Test Type, 2022-2030(USD Billion)
- Asia Pacific TB Diagnostics Market, By End-User, 2022-2030(USD Billion)
- Japan TB Diagnostics Market, By Test Type, 2022-2030(USD Billion)
- Japan TB Diagnostics Market, By End-User, 2022-2030(USD Billion)
- China TB Diagnostics Market, By Test Type, 2022-2030(USD Billion)
- China TB Diagnostics Market, By End-User, 2022-2030(USD Billion)
- India TB Diagnostics Market, By Test Type, 2022-2030(USD Billion)
- India TB Diagnostics Market, By End-User, 2022-2030(USD Billion)
- South America TB Diagnostics Market, By Test Type, 2022-2030(USD Billion)
- South America TB Diagnostics Market, By End-User, 2022-2030(USD Billion)
- Brazil TB Diagnostics Market, By Test Type, 2022-2030(USD Billion)
- Brazil TB Diagnostics Market, By End-User, 2022-2030(USD Billion)
- The Middle East and Africa TB Diagnostics Market, By Test Type, 2022-2030(USD Billion)
- The Middle East and Africa TB Diagnostics Market, By End-User, 2022-2030(USD Billion)
- UAE TB Diagnostics Market, By Test Type, 2022-2030(USD Billion)
- UAE TB Diagnostics Market, By End-User, 2022-2030(USD Billion)
- South Africa TB Diagnostics Market, By Test Type, 2022-2030(USD Billion)
- South Africa TB Diagnostics Market, By End-User, 2022-2030(USD Billion)
List of Figures
- Global TB Diagnostics Market Segmentation
- TB Diagnostics Market: Research Methodology
- Market Size Estimation Methodology: Bottom-Up Approach
- Market Size Estimation Methodology: Top-down Approach
- Data Triangulation
- Porter’s Five Forces Analysis
- Value Chain Analysis
- Top investment pocket in the TB Diagnostics Market
- Top Winning Strategies, 2022-2030
- Top Winning Strategies, By Development, 2022-2030(%)
- Top Winning Strategies, By Company, 2022-2030
- Moderate Bargaining power of Buyers
- Moderate Bargaining power of Suppliers
- Moderate Bargaining power of New Entrants
- Low threat of Substitution
- High Competitive Rivalry
- Top Player Positioning, 2022
- Market Share Analysis, 2022
- Restraint and Drivers: TB Diagnostics Market
- TB Diagnostics Market Segmentation, By Test Type
- TB Diagnostics Market For Radiographic Test, By Region, 2022-2030 ($ Billion)
- TB Diagnostics Market For Laboratory Test, By Region, 2022-2030 ($ Billion)
- TB Diagnostics Market For Nucleic Acid Testing, By Region, 2022-2030 ($ Billion)
- TB Diagnostics Market For Cytokine Detection Test, By Region, 2022-2030 ($ Billion)
- TB Diagnostics Market For Drug Resistance Test, By Region, 2022-2030 ($ Billion)
- TB Diagnostics Market For Other Diagnostic Test Types, By Region, 2022-2030 ($ Billion)
- TB Diagnostics Market Segmentation, By End-User
- TB Diagnostics Market For Hospital/Clinics, By Region, 2022-2030 ($ Billion)
- TB Diagnostics Market For Diagnostics/Research Laboratory, By Region, 2022-2030 ($ Billion)
- TB Diagnostics Market For Other End Users, By Region, 2022-2030 ($ Billion)
- Procter & Gamble: Net Sales, 2022-2030 ($ Billion)
- Procter & Gamble: Revenue Share, By Segment, 2022 (%)
- Procter & Gamble: Revenue Share, By Region, 2022 (%)
- PHYTOMER: Net Sales, 2022-2030 ($ Billion)
- PHYTOMER: Revenue Share, By Segment, 2022 (%)
- PHYTOMER: Revenue Share, By Region, 2022 (%)
- Deka Corporation: Net Sales, 2022-2030 ($ Billion)
- Deka Corporation: Revenue Share, By Segment, 2022 (%)
- Deka Corporation: Revenue Share, By Region, 2022 (%)
- Johnson & Johnson: Net Sales, 2022-2030 ($ Billion)
- Johnson & Johnson: Revenue Share, By Segment, 2022 (%)
- Johnson & Johnson: Revenue Share, By Region, 2022 (%)
- Unilever Plc.: Net Sales, 2022-2030 ($ Billion)
- Unilever Plc.: Revenue Share, By Segment, 2022 (%)
- Unilever Plc.: Revenue Share, By Region, 2022 (%)
- Kao Corporation: Net Sales, 2022-2030 ($ Billion)
- Kao Corporation: Revenue Share, By Segment, 2022 (%)
- Kao Corporation: Revenue Share, By Region, 2022 (%)
- ZO Skin Health, Inc.: Net Sales, 2022-2030 ($ Billion)
- ZO Skin Health, Inc.: Revenue Share, By Segment, 2022 (%)
- ZO Skin Health, Inc.: Revenue Share, By Region, 2022 (%)
- L’Oreal Paris: Net Sales, 2022-2030 ($ Billion)
- L’Oreal Paris: Revenue Share, By Segment, 2022 (%)
- L’Oreal Paris: Revenue Share, By Region, 2022 (%)
- Shiseido Company Limited: Net Sales, 2022-2030 ($ Billion)
- Shiseido Company Limited: Revenue Share, By Segment, 2022 (%)
- Shiseido Company Limited: Revenue Share, By Region, 2022 (%)
- Estee Lauder Companies, Inc.: Net Sales, 2022-2030 ($ Billion)
- Estee Lauder Companies, Inc.: Revenue Share, By Segment, 2022 (%)
- Estee Lauder Companies, Inc.: Revenue Share, By Region, 2022 (%)
Need help to buy this report?
Inquiry Before Buy